tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Financial Statements

Compare
563 Followers

Brainstorm Cell Therapeutics Financial Overview

Brainstorm Cell Therapeutics's market cap is currently $8.73M. The company's EPS TTM is $-0.45; its P/E ratio is ―; Brainstorm Cell Therapeutics is scheduled to report earnings on May 16, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 849.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 849.00K$ -265.00K$ -285.00K$ -260.00K$ -219.00K
Operating Income$ 0.00$ -21.44M$ -24.82M$ -24.54M$ -31.68M
EBITDA$ 0.00$ -16.93M$ -23.99M$ -24.28M$ -31.46M
Net Income$ 11.62M$ -17.19M$ -24.28M$ -24.46M$ -31.81M
Balance Sheet
Cash & Short-Term Investments$ 187.00K$ 1.30M$ 2.98M$ 22.09M$ 41.94M
Total Assets$ 1.83M$ 4.21M$ 8.45M$ 29.28M$ 51.26M
Total Debt$ 720.00K$ 672.00K$ 4.09M$ 5.08M$ 7.22M
Net Debt$ 533.00K$ -628.00K$ 3.32M$ -13.78M$ -30.61M
Total Liabilities$ 9.60M$ 9.07M$ 11.47M$ 9.94M$ 15.79M
Stockholders' Equity$ -7.76M$ -4.86M$ -3.02M$ 19.34M$ 35.46M
Cash Flow
Free Cash Flow$ -9.09M$ -20.48K$ -19.35M$ -26.59M$ -35.57M
Operating Cash Flow$ -9.09M$ -20.46M$ -19.32M$ -26.27M$ -35.19M
Investing Cash Flow$ 12.00K$ 2.19M$ 998.00K$ 323.00K$ -4.45M
Financing Cash Flow$ 7.97M$ 18.98M$ 238.00K$ 6.97M$ 76.94M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

Brainstorm Cell Therapeutics Debt to Assets

Brainstorm Cell Therapeutics Cash Flow

Brainstorm Cell Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis